Skip to main content
# Title Department Research Member Research Year
91 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
92 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Prof. Eman Massad Zaki El-Hefny 2022
93 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
94 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Dalia Osama Mohamed Ahmed 2022
95 Pattern and Outcome of Neurological Complications During the Treatment of Pediatric Acute Leukemias in Upper Egypt Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
96 The Advantage of Drug-Eluting Trans-Arterial Chemo-embolization Over The Conventional Technique in The Management of Hepatocellular Carcinoma (Bi-Institutional Study) Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2022
97 Lectin-Like OLR1 3′ UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes Department of Anesthesia, Intensive care and Pain management Dr. Mohamed Ahmed Mohamed Mostafa 2022
98 Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized … Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2022
99 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
100 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022